PENICILLIN-2 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Penicillin-2, and when can generic versions of Penicillin-2 launch?
Penicillin-2 is a drug marketed by Teva and is included in one NDA.
The generic ingredient in PENICILLIN-2 is penicillin g potassium. There are ninety-two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the penicillin g potassium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Penicillin-2
A generic version of PENICILLIN-2 was approved as penicillin g potassium by SANDOZ on August 30th, 2002.
Summary for PENICILLIN-2
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 71 |
Clinical Trials: | 190 |
Patent Applications: | 1,581 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PENICILLIN-2 at DailyMed |
Recent Clinical Trials for PENICILLIN-2
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Missouri-Columbia | Phase 4 |
Frieder Schaumburg | Phase 4 |
Abdul El-Rabbany | Phase 4 |
US Patents and Regulatory Information for PENICILLIN-2
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva | PENICILLIN-2 | penicillin g potassium | FOR SOLUTION;ORAL | 060307-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |